Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Exscientia Plc EXAI

Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI platform includes Precision Target, Precision Design, Precision Experiment, Precision Medicine, Presentations and Publications. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Its advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.


NDAQ:EXAI - Post by User

Post by shaker13on Jan 07, 2022 6:20am
175 Views
Post# 34291893

Interesting new entrant to the AI PubCo space

Interesting new entrant to the AI PubCo space

I'm comfortable with the size of my position I now have built in :
https://www.datametrex.com/

But because of my position and due diligence in V.DM I have now become aware of how huge the AI space is going to be and how because of the maturity of machine & deep learning, I'm now convinced AI's time is now.

Also observing the sheer volume of hot money flowing into this space like Exscientia $500M Raise, tells me AI is  & will continue to be the place to be for the foreseeable future.

So now I'm interested to branch out and take positions in other up & comers in the AI space , maybe even get in on a early Unicorn by luck, who knows?

Perhaps Exscientia
(despite the Cheesey-Geek name) could be one AI play on drug discovery to have a small piece in?

They look to be cashed up pretty good, only thing that could be a risk is the timeline involved for them to build a huge client base.
Sanofi is sure a great start tho.

If anyone can share competitors to Exscientia or other emerging & exciting AI Plays I'd appreciate it.
As I think I'll have some pretty healthy profits from V.DM to spread around and deploy to new homes later this year :-)

Safe harbor:
That's not a buy recommendation and I'm not a professional analyst of any kind , just a average Joe trying to catch a break by taking a hedge position on some of the technology that's suppose to take up to 60% our jobs, so strongly urge everyone do their own due diligence on any stock and consult a professional 

Happy & Profitable New Year to anyone reading this first post here.

Bullboard Posts
Next >>